Compugroup Medical (Germany) Performance

COP Stock  EUR 27.10  0.10  0.37%   
On a scale of 0 to 100, Compugroup Medical holds a performance score of 12. The firm shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Compugroup Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Compugroup Medical is expected to be smaller as well. Please check Compugroup Medical's standard deviation, treynor ratio, downside variance, as well as the relationship between the total risk alpha and value at risk , to make a quick decision on whether Compugroup Medical's price patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Compugroup Medical SE are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Compugroup Medical displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield
0.0021
Payout Ratio
0.1667
Last Split Factor
25:1
Ex Dividend Date
2025-08-04
Last Split Date
2006-10-23
1
The Truth About CompuGroup Medical Is This Sleepy German Stock About To Go Viral - AD HOC NEWS
01/13/2026
2
A Look At The Fair Value Of CompuGroup Medical SE Co. KGaA - simplywall.st
02/11/2026
  

Compugroup Medical Relative Risk vs. Return Landscape

If you would invest  2,372  in Compugroup Medical SE on November 18, 2025 and sell it today you would earn a total of  328.00  from holding Compugroup Medical SE or generate 13.83% return on investment over 90 days. Compugroup Medical SE is generating 0.2255% of daily returns assuming 1.3875% volatility of returns over the 90 days investment horizon. Simply put, 12% of all stocks have less volatile historical return distribution than Compugroup Medical, and 96% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Compugroup Medical is expected to generate 1.84 times more return on investment than the market. However, the company is 1.84 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of risk.

Compugroup Medical Target Price Odds to finish over Current Price

The tendency of Compugroup Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 27.10 90 days 27.10 
about 6.15
Based on a normal probability distribution, the odds of Compugroup Medical to move above the current price in 90 days from now is about 6.15 (This Compugroup Medical SE probability density function shows the probability of Compugroup Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Compugroup Medical has a beta of 0.13 suggesting as returns on the market go up, Compugroup Medical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Compugroup Medical SE will be expected to be much smaller as well. Additionally Compugroup Medical SE has an alpha of 0.1569, implying that it can generate a 0.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Compugroup Medical Price Density   
       Price  

Predictive Modules for Compugroup Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Compugroup Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
25.5926.9828.37
Details
Intrinsic
Valuation
LowRealHigh
23.0224.4129.70
Details

Compugroup Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Compugroup Medical is not an exception. The market had few large corrections towards the Compugroup Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Compugroup Medical SE, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Compugroup Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.16
β
Beta against Dow Jones0.13
σ
Overall volatility
1.18
Ir
Information ratio 0.08

Compugroup Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Compugroup Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Compugroup Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 50.0% of the company shares are held by company insiders
Latest headline from news.google.com: A Look At The Fair Value Of CompuGroup Medical SE Co. KGaA - simplywall.st

Compugroup Medical Fundamentals Growth

Compugroup Stock prices reflect investors' perceptions of the future prospects and financial health of Compugroup Medical, and Compugroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugroup Stock performance.

About Compugroup Medical Performance

By examining Compugroup Medical's fundamental ratios, stakeholders can obtain critical insights into Compugroup Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Compugroup Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Compugroup Medical is entity of Germany. It is traded as Stock on HM exchange.

Things to note about Compugroup Medical performance evaluation

Checking the ongoing alerts about Compugroup Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 50.0% of the company shares are held by company insiders
Latest headline from news.google.com: A Look At The Fair Value Of CompuGroup Medical SE Co. KGaA - simplywall.st
Evaluating Compugroup Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Compugroup Medical's stock performance include:
  • Analyzing Compugroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugroup Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Compugroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Compugroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugroup Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Compugroup Medical's stock. These opinions can provide insight into Compugroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Compugroup Medical's stock performance is not an exact science, and many factors can impact Compugroup Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Other Information on Investing in Compugroup Stock

Compugroup Medical financial ratios help investors to determine whether Compugroup Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Compugroup with respect to the benefits of owning Compugroup Medical security.